Literature DB >> 15139736

Severe acute respiratory syndrome (SARS): a review.

Pandurangan Vijayanand1, Ed Wilkins, Mark Woodhead.   

Abstract

Severe acute respiratory syndrome (SARS) is a newly emerged disease that rapidly spread around the world. The disease originated in southern China and a novel coronavirus (SARS CoV) has been implicated as the causative organism. The path this virus took to set up human infection remains a mystery, though preliminary data point to origins in an animal reservoir. Nosocomial transmission of SARS CoV has been a striking feature in this epidemic. The clinical illness is similar to many acute respiratory infections, although a large proportion of patients show a rapid deterioration with respiratory distress towards the end of the second week of illness. The management principles are broadly similar to treating any community acquired pneumonia but the infection control measures take a pivotal role. There is no proven antiviral agent against SARS CoV. The most remarkable feature about the SARS epidemic was the speed with which the global community acted in a coordinated way to control it.

Entities:  

Mesh:

Year:  2004        PMID: 15139736      PMCID: PMC4954004          DOI: 10.7861/clinmedicine.4-2-152

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  34 in total

1.  [SARS: solution by actions and responses with sense].

Authors:  José María Martín-Moreno
Journal:  Med Clin (Barc)       Date:  2004-11-13       Impact factor: 1.725

2.  Air circulation study inside and outside of urban buses induced by the opening of windows.

Authors:  Santiago Francisco Corzo; Dario Martin Godino; Damian Enrique Ramajo
Journal:  Environ Sci Pollut Res Int       Date:  2022-10-19       Impact factor: 5.190

Review 3.  Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective.

Authors:  Yashpal Singh Malik; Naveen Kumar; Shubhankar Sircar; Rahul Kaushik; Sudipta Bhat; Kuldeep Dhama; Parakriti Gupta; Kapil Goyal; Mini P Singh; Ujjala Ghoshal; Mohamed E El Zowalaty; VinodhKumar O R; Mohd Iqbal Yatoo; Ruchi Tiwari; Mamta Pathak; Shailesh Kumar Patel; Ranjit Sah; Alfonso J Rodriguez-Morales; Balasubramanian Ganesh; Prashant Kumar; Raj Kumar Singh
Journal:  Pathogens       Date:  2020-06-28

Review 4.  Current Trends in Diagnostics of Viral Infections of Unknown Etiology.

Authors:  Daniel Kiselev; Alina Matsvay; Ivan Abramov; Vladimir Dedkov; German Shipulin; Kamil Khafizov
Journal:  Viruses       Date:  2020-02-14       Impact factor: 5.048

Review 5.  Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence.

Authors:  Marko Kumric; Tina Ticinovic Kurir; Dinko Martinovic; Piero Marin Zivkovic; Josko Bozic
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

Review 6.  COVID Obesity: A One-Year Narrative Review.

Authors:  Diana L Palacios Ovalle; Susana Rodrigo-Cano; Aránzazu González; Carla Soler; Ana I Catalá-Gregori; J Francisco Merino-Torres; Jose M Soriano
Journal:  Nutrients       Date:  2021-06-16       Impact factor: 6.706

Review 7.  Coronaviridae-Old friends, new enemy!

Authors:  Jair Carneiro Leao; Teresa Paula de Lima Gusmao; Adriana Machado Zarzar; Jair Carneiro Leao Filho; Andreza Barkokebas Santos de Faria; Igor Henrique Morais Silva; Luiz Alcino Monteiro Gueiros; Narendran Andrew Robinson; Stephen Porter; Alessandra de Albuquerque Tavares Carvalho
Journal:  Oral Dis       Date:  2020-06-26       Impact factor: 4.068

Review 8.  SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic.

Authors:  Ali A Rabaan; Shamsah H Al-Ahmed; Ranjit Sah; Ruchi Tiwari; Mohd Iqbal Yatoo; Shailesh Kumar Patel; Mamta Pathak; Yashpal Singh Malik; Kuldeep Dhama; Karam Pal Singh; D Katterine Bonilla-Aldana; Shafiul Haque; Dayron F Martinez-Pulgarin; Alfonso J Rodriguez-Morales; Hakan Leblebicioglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-02       Impact factor: 3.944

Review 9.  Emerging viral threats to the Australian blood supply.

Authors:  Robert A Dunstan; Clive R Seed; Anthony J Keller
Journal:  Aust N Z J Public Health       Date:  2008-08       Impact factor: 2.939

10.  The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.

Authors:  Farhana Musarrat; Vladimir Chouljenko; Achyut Dahal; Rafiq Nabi; Tamara Chouljenko; Seetharama D Jois; Konstantin G Kousoulas
Journal:  J Med Virol       Date:  2020-05-17       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.